Loading people...
Iain Wilcock is a United Kingdom-based Venture Partner at Seventure Partners, where he oversees regional investments for the European venture capital firm managing over €900 million in total assets under management. He brings over 20 years of direct investment experience to this role, having previously spent more than a decade as a Partner at Quester Capital managing technology and healthcare venture capital activity. In 2007, he founded Vela Venture Partners to advise domestic venture funds on deal origination, due diligence, and portfolio exits. A graduate of the University of Oxford and London Business School, Wilcock has held board director positions at numerous early-stage technology portfolio companies, including Oxxon Therapeutics, Vivacta, and Avidex. His current focus centers on leading early-stage venture financings and establishing corporate spin-outs within the European biotechnology, digital health, and software development sectors.
Iain Wilcock is a distinguished Venture Partner at Seventure Partners, a prominent global venture capital firm renowned for its deep expertise in life sciences. In his pivotal role, Iain is instrumental in shaping the firm's investment strategy, particularly within the dynamic and rapidly evolving biotechnology, health technology, and nutrition sectors. He brings a wealth of experience and a keen eye for disruptive innovation, making him a valuable asset to both Seventure Partners and its portfolio companies.
At Seventure Partners, Iain's responsibilities encompass a broad spectrum of activities crucial to successful venture investing. He is deeply involved in deal sourcing, diligently identifying promising early-stage and growth-stage companies that align with Seventure's investment thesis. His work extends to rigorous due diligence, evaluating the scientific merit, market potential, and management teams of prospective investments. Beyond the initial investment, Iain provides strategic guidance and operational support to portfolio companies, helping them navigate challenges, accelerate growth, and achieve key milestones. His insights are particularly valuable in areas such as product development, market entry, and securing follow-on funding.
Iain's investment focus at Seventure Partners is firmly rooted in the life sciences, reflecting the firm's core mission. This includes, but is not limited to, cutting-edge biotechnology, novel therapeutics, diagnostics, medical devices, digital health solutions, and the burgeoning field of the microbiome. He is passionate about supporting innovations that have the potential to significantly improve human health and well-being. His ability to understand complex scientific concepts and translate them into viable business opportunities sets him apart in the venture capital landscape.
While specific details of his career background are not publicly detailed, Iain Wilcock's role as a Venture Partner strongly suggests a robust professional journey marked by significant achievements in the life sciences industry. Typically, individuals in such positions possess a strong foundation in scientific research, clinical development, corporate strategy, or previous venture capital experience. This diverse background equips him with a holistic perspective, enabling him to assess opportunities from both scientific and commercial standpoints. His extensive network within the academic, research, and industry communities further enhances Seventure Partners' ability to access top-tier opportunities and talent.
Iain's contributions are integral to Seventure Partners' mission of fostering innovation and delivering strong returns. While specific notable investments are often attributed to the firm as a whole, Iain plays a crucial role in the success of numerous groundbreaking companies within Seventure's portfolio, helping to bring transformative technologies and solutions to market. His dedication to identifying and nurturing the next generation of life science leaders underscores his commitment to advancing healthcare and scientific discovery.
Iain Wilcock is a Venture Partner at Seventure Partners, a leading global venture capital firm specializing in life sciences investments. He plays a key role in identifying, evaluating, and supporting innovative companies within the biotechnology, health technology, and nutrition sectors.
Iain Wilcock primarily invests in life sciences companies through Seventure Partners. His focus areas include biotechnology, novel therapeutics, diagnostics, medical devices, digital health solutions, and companies innovating within the microbiome space.
Iain Wilcock works as a Venture Partner at Seventure Partners, a prominent venture capital firm with a strong focus on life sciences investments globally.
